Skip to main navigation Skip to search Skip to main content

TECOS: Evaluation of Cardiovascular Outcomes after Treatment with Sitagliptin (MK-0431) in Patients with Type 2 Diabetes & Inadequate Glycemic Control on Mono- or Dual Combination Oral Antihyperglycemic Therapy, Protocol 082-00

Project: Research

Project Details

StatusFinished
Effective start/end date12/1/08 → 04/15/16

Funding

  • Merck and Company: $6,875.00